Safety and Performance of a Synthetic Tissue Sealant in Reducing Fluid Leakage in Hepatobiliary and Pancreatic Surgery

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

November 19, 2021

Study Completion Date

May 26, 2023

Conditions
PancreatectomyHepatic Resection
Interventions
DEVICE

Sealing Device

The Sealing Device is indicated for use in hepato-pancreato-biliary (HPB) surgery to reduce leakage of fluids from the site of surgery into the abdominal cavity and as an adjunctive hemostatic device to control minimal to moderate bleeding at the surgical site.

Trial Locations (2)

Unknown

Universitats Klinikum Hamburg-Eppendorf, Hamburg

University Hospital Oldenburg, Oldenburg

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Genae

INDUSTRY

lead

Polyganics BV

INDUSTRY